Exact Sciences’ Growth Potential Bolstered by Cologuard Plus and Medicare Advantage Expansion
Exact Sciences gains Buy ratings as Cologuard Plus expands in-network Medicare Advantage coverage, boosting reimbursement and revenue potential in cancer screening diagnostics.